Taken together, our data suggest that increased expression of Foxm1 likely enhances the self-renewal and survival of MA9 LSCs through multiple molecular pathways including the Wnt/β-catenin pathway, thereby contributing to the maintenance and drug resistance of MA9-induced leukemia. Here, FOXM1 is linked to leukemia.